Skip to content

The Amsterdam Cohort Study (ACS) on HIV infection/AIDS, and other bloodborne and sexually transmitted diseases among drug users.

The Amsterdam Cohort Study (ACS) on HIV infection/AIDS, and other bloodborne and sexually transmitted diseases among drug users. - Amsterdam Cohort Study among drug users.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32966
Enrollment
550
Registered
2009-09-04
Start date
2009-03-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hiv/AIDS, bloedoverdraagbare en seksueel overdraagbare en (hiv) gerelateerde aandoeningen nvt

Interventions

None listed

Sponsors

GGD Amsterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: drug users, living in the Netherlands, 18 years of age and older, signed Informed Consent, willing to fill out/answer questionnaires, willing to donate blood samples and other body tissue samples. Agreeing to be told results of medical tests.

Exclusion criteria

Exclusion criteria: not relevant: if inclusion criteria are fullfilled, the person can join the ACS

Design outcomes

Primary

MeasureTime frame
HIV-infection, bloodborne and sexually transmitted diseases and (HIV) related infections. (Genetic) markers of HIV-infection, bloodborne and sexually transmitted diseases and (HIV) related infections.

Secondary

MeasureTime frame
not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)